Dementia Discovery Fund
42
21M
23
4.67
7
0.43
2
- Stages of investment
- Areas of investment
Summary
In 2015 was created Dementia Discovery Fund, which is appeared as VC. The main office of represented VC is situated in the London. The fund was located in Europe if to be more exact in United Kingdom.
The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2019. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The top activity for fund was in 2018. Deals in the range of 10 - 50 millions dollars are the general things for fund. Opposing the other organizations, this Dementia Discovery Fund works on 12 percentage points less the average amount of lead investments.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Care, Life Science. Among the most popular portfolio startups of the fund, we may highlight Alector, MedaRed, Mitoconix Bio. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Dementia Discovery Fund, startups are often financed by SV Health Investors, Polaris Partners, OrbiMed. The meaningful sponsors for the fund in investment in the same round are AbbVie Biotech Ventures, Amgen Ventures, SV Health Investors. In the next rounds fund is usually obtained by Illumina Ventures, Amgen Ventures, AbbVie Biotech Ventures.
The overall number of key employees were 3.
Investments analytics
Analytics
- Total investments
- 42
- Lead investments
- 7
- Exits
- 2
- Rounds per year
- 4.67
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (32)
- Health Care (18)
- Therapeutics (17)
- Life Science (13)
- Pharmaceutical (9) Show 13 more
- Investments by region
-
- United States (23)
- United Kingdom (17)
- Israel (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.81
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| AstronauTx | 08 Oct 2023 | Pharmaceutical | Early Stage Venture | 65M | England, United Kingdom, United Kingdom |
| AviadoBio | 02 Dec 2021 | Early Stage Venture | 80M | England, London, United Kingdom |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.